At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists who are committed to improving the lives of patients.

Our approach focuses on lipid mediators that target the underlying etiology of complex human diseases. The Catabasis proprietary platform has produced a pipeline of products that incorporates the Catabasis SMART-linker technology.